Portella G, Cumming S A, Liddell J, Cui W, Ireland H, Akhurst R J, Balmain A
Department of Medical Oncology, Glasgow University, United Kingdom.
Cell Growth Differ. 1998 May;9(5):393-404.
Transforming growth factor beta1 (TGF-beta1) regulates both cell growth and cellular plasticity and is therefore important in the molecular control of both the developmental and neoplastic processes. It has been suggested that TGF-beta1 may be a positive or negative regulator of tumorigenesis. Stimulation of tumorigenesis could be due to its action as an immunosuppressor or as an inducer of angiogenesis, or by its direct action on the cell in promoting cellular plasticity. In the current study, we provide evidence that TGF-beta1 can act directly on keratinocytes in vivo to induce the reversible epithelial-mesenchymal conversion of a malignant metastatic keratinocyte cell line. Two squamous clones from the cell line were shown to undergo a reversible conversion to a fibroblastoid phenotype after culture in 1 ng/ml TGF-beta1. The morphological conversion became apparent at 24 h post-TGF-beta treatment and was complete after another 24 h. The conversion was characterized by a rapid delocalization of E-cadherin within 6-12 h posttreatment, followed by down-regulation of E-cadherin levels by 72 h. These squamous clones spontaneously converted to a fibroblastoid phenotype after s.c. injection in nude mice. Importantly, four of four clones that had been stably transfected with a dominant negative TGF-beta type II receptor were unable to undergo this mesenchymal switch in vivo, despite the fact that all clones stably transfected with neomyocin resistance alone retained their spindle characteristics in vivo. This demonstrates that the epithelial-mesenchymal conversion event is mediated directly via the TGF-beta signaling pathway of the tumor cell per se, and that it is sufficient to significantly enhance tumorigenicity and the malignant and invasive characteristics of the tumor in vivo.
转化生长因子β1(TGF-β1)可调节细胞生长和细胞可塑性,因此在发育过程和肿瘤形成过程的分子调控中都很重要。有人提出,TGF-β1可能是肿瘤发生的正向或负向调节因子。肿瘤发生的刺激可能归因于其作为免疫抑制剂或血管生成诱导剂的作用,或者是其对细胞促进细胞可塑性的直接作用。在本研究中,我们提供证据表明,TGF-β1可在体内直接作用于角质形成细胞,诱导恶性转移性角质形成细胞系发生可逆的上皮-间质转化。该细胞系的两个鳞状克隆在1 ng/ml TGF-β1中培养后,显示出可逆地转化为成纤维细胞样表型。TGF-β处理后24小时,形态学转化变得明显,再过24小时完成。这种转化的特征是,处理后6-12小时内E-钙黏蛋白迅速发生去定位,随后72小时E-钙黏蛋白水平下调。这些鳞状克隆在裸鼠皮下注射后自发转化为成纤维细胞样表型。重要的是,四个稳定转染了显性负性TGF-β II型受体的克隆在体内无法发生这种间质转换,尽管所有仅稳定转染了新霉素抗性的克隆在体内都保留了其纺锤体特征。这表明上皮-间质转化事件是直接通过肿瘤细胞本身的TGF-β信号通路介导的,并且足以在体内显著增强肿瘤发生能力以及肿瘤的恶性和侵袭性特征。